Material-Methods
After ethical committee approval and permission being granted by the Republic of Turkey Ministry of Health, the data of COVID-19 patients who were hospitalized between 15 May and 15 June 2020 at a tertiary center were collected retrospectively. The patients who were <18 years old, had any type of chronic medical illness, or any type of urinary cancers or history of urological operations were excluded from the study. The remaining patients were contacted and asked if they wanted to participate in the study. All of the patients agreed to participate and complete the questionnaires.
All patients answered socio-demographic form questions. Then the Male patients then replied to the questions of the International Prostate Symptom Score (IPSS), and female patients responded to the questions of the Urinary Symptom Profile (USP). Both male and female patients responded to these questions three times, based on their condition pre-COVID-19, during hospitalization, and post-hospitalized time. LUTS can be evaluated with a total IPSS score, and with this score system voiding and storage symptoms can be detected separately (10-19). USP, which was designed by Haab et al (11-8), and translated in Turkish by Bilge and Beji(11), has been used for both men and women who have stress incontinence, an overactive bladder, and/or obstructive symptoms.
The SPSS 21.0 program was used in the statistical analysis of the data. The variables were expressed as mean ± standard deviation (X ± SD), and the percent (%) value was calculated for variables determined by the count. The “p” significance value was taken as 0.05 in all the statistical analyses.